Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 1, 2008, Pages 235-242

  Nehmeh, Sadek A ^a   Lee, Nancy Y ^a   Schröder, Heiko ^a   Squire, Olivia ^a   Zanzonico, Pat B ^a   Erdi, Yusuf E ^a   Greco, Carlo ^a   Mageras, Gig ^a   Pham, Hai S ^a   Larson, Steve M ^a   Ling, Clifton C ^a   Humm, John L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

18F fluoromisonidazole; 18F FMISO; Head and neck cancer; Hypoxia

Indexed keywords

CELLS; COMPUTERIZED TOMOGRAPHY; ONCOLOGY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY;

F-FLUOROMISONIDAZOLE; HEAD AND NECK CANCER; HYPOXIA;

TUMORS;

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DRUG DISTRIBUTION; DRUG UPTAKE; HEAD AND NECK CANCER; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY;

AGED; CELL HYPOXIA; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MISONIDAZOLE; POSITRON-EMISSION TOMOGRAPHY; RADIATION-SENSITIZING AGENTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 37049004518     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.08.036     Document Type: Article

References (38)

1. Dubois L., Landuyt W., Haustermans K., et al. Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry. Br J Cancer 91 (2004) 1947-1954
2. Chapman J.D. The detection and measurement of hypoxic cells in solid tumors. Cancer 54 (2006) 2441-2449
3. Vaupel P., Kallinowski F., and Ohunieff P. Blood flow, oxygen and nutrient supply, and metabolic micro-environment of human tumors: Review. Cancer Res 49 (1989) 6449-6465
4. Brizel D.M., Rosner G.L., Harrelson J., et al. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 30 (1994) 635-642
5. Nordsmark M., Bentzen S.M., and Rudat V. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy: An international multi-center study. Radiother Oncol 77 (2005) 18-24
6. Koukourakis M.I., Bentzen S.M., Giatromanolaki A., et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 24 (2006) 727-735
7. Bussink J., Kaanders J.H., and van der Kogel A.J. Tumor hypoxia at the micro-regional level: Clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 67 (2003) 3-15
8. Rasey J.S., Hofstrand P.D., Chin L.K., et al. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia. J Nucl Med 40 (1999) 1072-1079
9. Nordsmark M., Loncaster J., Chou S.C., et al. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int J Radiat Oncol Biol Phys 49 (2001) 581-586
10. Fyles A., Milosevic M., Hedley D., et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20 (2002) 680-687
11. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26 (1993) 45-50
12. Knowles H.J., and Phillips R.M. Identification of differentially expressed genes in experimental models of the tumor microenvironment using differential display. Anticancer Res 21 (2001) 2305-2311
13. Mankoff D.A., Dunnwald L.K., Gralow J.R., et al. Blood flow and metabolism in locally advanced breast cancer: Relationship to response to therapy. J Nucl Med 43 (2002) 500-509
14. Valk P., Mathis C., Prados M., et al. Hypoxia in human gliomas: Demonstration by PET with flouorine-18-fluoromisonidazole. J Nucl Med 33 (1992) 2133-2137
15. Hockel M., Schlenger K., Arad D., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 (1996) 4509-4515
16. Adam M., Gabalski E.C., Bloch D.A., et al. Tissue oxygen distribution in head and neck cancer patients. Head Neck 21 (1999) 146-153
17. Brizel D.M., Sibley G.S., Prosnitz L.R., et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38 (1997) 285-289
18. Rajendran J.G., Mankoff D.A., O'Sullivan F., et al. Hypoxia glucose metabolism in malignant tumors: Evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 10 (2004) 2245-2252
19. Rajendran J.G., Wilson D.C., Conrad E.U., et al. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: Correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 30 (2003) 695-704 Epub 2003 Mar
20. Rasey J.S., Koh W.J., Evans M.L., et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 36 (1996) 417-428
21. Gagel B., Reinartz P., Dimartino E., et al. pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2′-deoxyglucose): An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol 180 (2004) 616-622
22. Eschmann S.M., Paulsen F., Reimold M., et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46 (2005) 253-260
23. Koh W.J., Bergman K.S., Rasey J.S., et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys 33 (1995) 391-398
24. Casciari J.J., Graham M.M., and Rasey J.S. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. Med Phys 22 (1995) 1127-1139
25. Rajendran J.G., and Krohn K.A. Imaging hypoxia and angiogenesis in tumors. Radiol Clin North Am 43 (2005) 169-187
26. Overgaard J., and Horsman M.R. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 6 (1996) 10-21
27. Evans S.M., and Koch C.J. Prognostic significance of tumor oxygenation in humans. Cancer Lett 195 (2003) 1-16
28. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
29. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
30. Hu Y., Erdi A., and Chui C. A 3-D image registration toolkit for radiation therapy treatment planning. [Abstract]. Med Phys 26 (1999) 1160
31. Erdi A.K., Hu Y.C., and Chui C.S. Using mutual information (MI) for automated 3D registration in the pelvis and thorax region for radiotherapy treatment planning. Proc SPIE Med Imaging 3979 (2000) 416-425
32. Nehmeh S., El-Zeftawy H., Erdi Y., et al. An iterative technique for lesion segmentation in PET images. [Abstract]. J Nucl Med 47 (2006) 364. Accessed at www.graylab.ac.uk/lab/reviews/hypoxia/html
33. ImageJ. Available from: http://rsb.info.nih.gov/ij. Accessed June 2006.
34. Hodg Kiss RJ. Predictive assays for tumour hypoxia: Where are we going? 1993 Gray Laboratory Annual Report.
35. Hall E.J. Radiobiology for the radiologist. 6th ed (2005), Lippincott Williams&Wilkins, Philadelphia
36. Garrecht B.M., and Chapman J.D. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole. Br J Radiol 56 (1983) 745-753
37. Hong T., Tomé W., Chappell R., et al. The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 61 (2005) 779-788
38. 18FMISO-PET: Modeling transient and chronic hypoxia. [Abstract]. Int J Radiat Oncol Biol Phys 66 Suppl (2006) S3